| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IRON | Common Stock | Sale | $866,304 | -14,400 | -1.2% | $60.16 | 1,182,425 | 12 Dec 2023 | See footnotes | F1, F4 |
| transaction | IRON | Common Stock | Sale | $559,488 | -9,300 | -1.2% | $60.16 | 764,307 | 12 Dec 2023 | See footnotes | F2, F4 |
| transaction | IRON | Common Stock | Sale | $216,576 | -3,600 | -1.2% | $60.16 | 295,605 | 12 Dec 2023 | See footnotes | F3, F4 |
| transaction | IRON | Common Stock | Sale | $3,291,072 | -56,200 | -4.8% | $58.56 | 1,126,225 | 13 Dec 2023 | See footnotes | F1, F4 |
| transaction | IRON | Common Stock | Sale | $2,131,584 | -36,400 | -4.8% | $58.56 | 727,907 | 13 Dec 2023 | See footnotes | F2, F4 |
| transaction | IRON | Common Stock | Sale | $825,696 | -14,100 | -4.8% | $58.56 | 281,505 | 13 Dec 2023 | See footnotes | F3, F4 |
| transaction | IRON | Common Stock | Sale | $5,773 | -100 | -0.01% | $57.73 | 1,126,125 | 14 Dec 2023 | See footnotes | F1, F4 |
| transaction | IRON | Common Stock | Sale | $5,773 | -100 | -0.01% | $57.73 | 727,807 | 14 Dec 2023 | See footnotes | F2, F4 |
| Id | Content |
|---|---|
| F1 | These securities are held of record by OrbiMed Private Investments VIII, LP ("OPI VIII"). OrbiMed Capital GP VIII LLC ("GP VIII") is the general partner of OPI VIII and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP VIII. The Reporting Person is an employee of OrbiMed Advisors. By virtue of such relationships, GP VIII and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OPI VIII and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI VIII. |
| F2 | These securities are held of record by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors is the managing member of GP VI. By virtue of such relationships, GP VI and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI VI. |
| F3 | These securities are held of record by OrbiMed Genesis Master Fund, L.P. ("Genesis"). OrbiMed Genesis GP LLC ("Genesis GP") is the general partner of Genesis and OrbiMed Advisors is the managing member of Genesis GP. By virtue of such relationships, Genesis GP and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by Genesis and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by Genesis. |
| F4 | Each of the Reporting Person, OrbiMed Advisors, GP VIII, GP VI, and Genesis GP disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of her or its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Person, OrbiMed Advisors, GP VIII, GP VI, or Genesis GP is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose. |